About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Brain Stimulation for Neurological Patients | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT03770182

Brain Stimulation for Neurological Patients

This is a prospective double-blind randomized placebo-controlled crossover clinical trial

Lead sponsor: Storz Medical AG•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Storz Medical AG

Collaborators

Medical University of Vienna

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Clinically stable patients with probable Alzheimer's Disease (Diagnosis according to ICD-10 Criteria (F00))
•At least 3 months of stable antidementive therapy or no antidementive therapy necessary
•Signed written informed consent
•Monthly pregnancy test for women in childbearing years
•Age \>= 18 years

Exclusion Criteria

•Non-compliance with the protocol
•Pregnant or breastfeeding women
•Relevant intracerebral pathology unrelated to the Alzheimers's disease (e.g. Brain tumor)
•Hemophilia or other blood clotting disorders
•Cortisone treatment within the last 6 weeks before first treatment
•Thrombosis

Related studies

RECRUITINGPhase 3

Donanemab (LY3002813) Trial in Chinese Participants With Cognitively Unimpaired (Preclinical) Alzheimer's Disease

NCT07571161 · Alzheimer Disease

RECRUITINGPhase 2

Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

NCT06847321 · Alzheimer Disease, Alzheimer Disease Due to P. Gingivalis

RECRUITINGPhase 3

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

NCT06937229 · Alzheimer Disease, Agitation

Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)

NCT04579120 · Alzheimer Disease

RECRUITINGPhase 4

A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)

NCT07633470 · Alzheimer Disease

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 22, 2023Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment60

Start dateJan 2017

Last updatedNov 22, 2023

Condition

Alzheimer Disease

Locations shown

Medical University of Vienna

Vienna

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 22, 2023Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions